Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9472334rdf:typepubmed:Citationlld:pubmed
pubmed-article:9472334lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:9472334lifeskim:mentionsumls-concept:C0238760lld:lifeskim
pubmed-article:9472334lifeskim:mentionsumls-concept:C1519941lld:lifeskim
pubmed-article:9472334pubmed:dateCreated1998-3-4lld:pubmed
pubmed-article:9472334pubmed:abstractTextWe conducted a methodologic study to validate a quantitative retrospective exposure assessment method used in a follow-up study of workers exposed to benzene. Assessment of exposure to benzene was carried out in 672 factories in 12 cities in China. Historical exposure data were collected for 3179 unique job titles. The basic unit for exposure assessment was a factory/work-unit/job-title combination over seven periods between 1949 and 1987. A total of 18,435 exposure estimates was developed, using all available historical information, including 8477 monitoring data. Overall, 38% of the estimates were based on benzene monitoring data. The highest time-weighted average exposures occurred in the rubber industry (30.7 ppm), particularly for rubber glue applicators (52.6 ppm). Because of its recognized link with benzene exposure, the association between a clinical diagnosis of benzene poisoning (hematotoxicity) and benzene exposure was evaluated (412 cases and 614,509 person-years) to validate the exposure-assessment method. Relative risks of benzene hematotoxicity increased very sharply with increasing estimated intensity of benzene exposure. Odds ratios were 2.2 (95% CI: 1.7-2.9), 4.7 (95% CI: 3.4-6.5), and 7.2 (95% CI: 5.3-9.8) for the intensity levels of less than 5 ppm, 5-19 ppm, 20-39 ppm, and 40 and more ppm, respectively. This sharp trend between benzene hematotoxicity and estimated exposure to benzene indicated that the exposure-estimation method used in this cancer epidemiology study is reliable.lld:pubmed
pubmed-article:9472334pubmed:languageenglld:pubmed
pubmed-article:9472334pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9472334pubmed:citationSubsetIMlld:pubmed
pubmed-article:9472334pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9472334pubmed:statusMEDLINElld:pubmed
pubmed-article:9472334pubmed:monthDeclld:pubmed
pubmed-article:9472334pubmed:issn0077-8923lld:pubmed
pubmed-article:9472334pubmed:authorpubmed-author:WacholderSSlld:pubmed
pubmed-article:9472334pubmed:authorpubmed-author:HayesR BRBlld:pubmed
pubmed-article:9472334pubmed:authorpubmed-author:DAYRRlld:pubmed
pubmed-article:9472334pubmed:authorpubmed-author:YimS OSOlld:pubmed
pubmed-article:9472334pubmed:authorpubmed-author:GALLHHlld:pubmed
pubmed-article:9472334pubmed:authorpubmed-author:DosemeciMMlld:pubmed
pubmed-article:9472334pubmed:authorpubmed-author:RothmanNNlld:pubmed
pubmed-article:9472334pubmed:authorpubmed-author:LinetMMlld:pubmed
pubmed-article:9472334pubmed:issnTypePrintlld:pubmed
pubmed-article:9472334pubmed:day26lld:pubmed
pubmed-article:9472334pubmed:volume837lld:pubmed
pubmed-article:9472334pubmed:ownerNLMlld:pubmed
pubmed-article:9472334pubmed:authorsCompleteYlld:pubmed
pubmed-article:9472334pubmed:pagination114-21lld:pubmed
pubmed-article:9472334pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9472334pubmed:meshHeadingpubmed-meshheading:9472334-...lld:pubmed
pubmed-article:9472334pubmed:meshHeadingpubmed-meshheading:9472334-...lld:pubmed
pubmed-article:9472334pubmed:meshHeadingpubmed-meshheading:9472334-...lld:pubmed
pubmed-article:9472334pubmed:meshHeadingpubmed-meshheading:9472334-...lld:pubmed
pubmed-article:9472334pubmed:meshHeadingpubmed-meshheading:9472334-...lld:pubmed
pubmed-article:9472334pubmed:meshHeadingpubmed-meshheading:9472334-...lld:pubmed
pubmed-article:9472334pubmed:meshHeadingpubmed-meshheading:9472334-...lld:pubmed
pubmed-article:9472334pubmed:meshHeadingpubmed-meshheading:9472334-...lld:pubmed
pubmed-article:9472334pubmed:meshHeadingpubmed-meshheading:9472334-...lld:pubmed
pubmed-article:9472334pubmed:meshHeadingpubmed-meshheading:9472334-...lld:pubmed
pubmed-article:9472334pubmed:meshHeadingpubmed-meshheading:9472334-...lld:pubmed
pubmed-article:9472334pubmed:year1997lld:pubmed
pubmed-article:9472334pubmed:articleTitleValidation of benzene exposure assessment.lld:pubmed
pubmed-article:9472334pubmed:affiliationDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA. DosemecM@EPNDCE.NCI.NIH.GOVlld:pubmed
pubmed-article:9472334pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9472334lld:pubmed